Stroke victims to get hallucinogenic drug in first-of-its-kind study, scientists say

Stroke victimes will be given DMT - or dimethyltryptamine - during the study, scientists say. They argue the drug will stimulate the re-growth of nerve cells, speeding up the healing process.